Travere Therapeutics
TVTX
TVTX
129 hedge funds and large institutions have $1.1B invested in Travere Therapeutics in 2018 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 46 increasing their positions, 46 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
129
Holders Change
+10
Holders Change %
+8.4%
% of All Funds
2.96%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
21
Increased
46
Reduced
46
Closed
11
Calls
$9.96M
Puts
$1.37M
Net Calls
+$8.59M
Net Calls Change
+$949K
Top Buyers
| 1 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
+$40.6M |
| 2 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
+$6.93M |
| 3 |
BlackRock
New York
|
+$6.81M |
| 4 |
State Street
Boston,
Massachusetts
|
+$5.18M |
| 5 |
Russell Investments Group
London,
United Kingdom
|
+$5.08M |
Top Sellers
| 1 |
Invesco
Atlanta,
Georgia
|
-$19.4M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$13.7M |
| 3 |
Millennium Management
New York
|
-$9.22M |
| 4 |
GTC
Ghost Tree Capital
New York
|
-$7.03M |
| 5 |
AC
Ascend Capital
Orinda,
California
|
-$5.83M |
